Electronic medical record review of de-identified patients who tested positive for COVID-19 (using a PCR test) at Methodist Dallas Medical Center (MDMC) from June 2020 until the date of IRB approval. Data will be collected on de-identified patients that test positive for COVID-19 (using a PCR test) at MDMC from the date of IRB approval until December 2022. Disclaimer: Any cost associated with the procedures stated herein will be billed directly to you or to your insurance (as applicable)
Electronic medical record review of de-identified patients who tested positive for COVID-19
(using a PCR test) at Methodist Dallas Medical Center (MDMC) from June 2020 until the date of
IRB approval. Data will be collected on de-identified patients that test positive for
COVID-19 (using a PCR test) at MDMC from the date of IRB approval until December 2022.
Variables include patient baseline characteristics, patient presentation, imaging and labs.
Disclaimer: Any cost associated with the procedures stated herein will be billed directly to
you or to your insurance (as applicable)
Other: Chart review
Chart review
Inclusion Criteria:
- Hospitalized patient
- Adult over 18 years
- Positive COVID-19 PCR Test
Exclusion Criteria:
- None
Methodist Dallas Medical Center
Dallas, Texas, United States
Manavjot Sidhu, MD, Principal Investigator
Methodist Health System